礼来表示,将从9月开始提高其重磅糖尿病药物Mounjaro在英国的定价,以回应美国总统特朗普向制药商施压,要求其降低美国药品价格并提高海外药品价格。公司指,与英国政府达成协议,提高每周注射剂的标价,同时维持公共资助医疗体系、国家医疗服务体系涵盖患者的使用权。
礼来表示,将从9月开始提高其重磅糖尿病药物Mounjaro在英国的定价,以回应美国总统特朗普向制药商施压,要求其降低美国药品价格并提高海外药品价格。公司指,与英国政府达成协议,提高每周注射剂的标价,同时维持公共资助医疗体系、国家医疗服务体系涵盖患者的使用权。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.